![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. Delta Sleep Inducing Peptide
2. Delta Sleep Peptide
3. Delta Sleep-inducing Peptide
4. Delta-sleep Peptide
5. Delta-sleep-inducing Peptide
6. Delta-sleep-inducing-peptide
7. Dsip
8. Peptide, Delta Sleep-inducing
9. Peptide, Delta-sleep
10. Peptide, Delta-sleep-inducing
11. Sleep-inducing Peptide, Delta
12. Trp Ala Gly Gly Asp Ala Ser Gly Glu
13. Trp-ala-gly-gly-asp-ala-ser-gly-glu
1. 62568-57-4
2. Dsip
3. Delta Sleep Inducing Peptide
4. Trp-ala-gly-gly-asp-ala-ser-gly-glu
5. Delta Sleep-inducing Peptide
6. Dsip Nonapeptide
7. Emideltide [inn]
8. L-tryptophyl-l-alanylglycylglycyl-l-aspartyl-l-alanyl-l-serylglycyl-l-glutamic Acid
9. Delta Sleep-inducing Peptide (rabbit)
10. Unii-yn28z5yz73
11. Delta-sleep Inducing Peptide
12. O-sleep Inducing Peptide
13. Deltasleep-inducing Peptide
14. L-glutamic Acid, L-tryptophyl-l-alanylglycylglycyl-l-alpha-aspartyl-l-alanyl-l-serylglycyl-
15. 69431-45-4
16. L-glutamic Acid, N-(n-(n-(n-(n-(n-(n-(n-l-tryptophyl-l-alanyl)glycyl)glycyl)-l-alpha-aspartyl)-l-alanyl)-l-seryl)-glycyl)-
17. Schembl5523017
18. Yn28z5yz73
19. Chembl2104403
20. Dtxsid20978151
21. Glxc-25919
22. Hy-p1501
23. Zinc169292552
24. L-tryptophyl-l-alanylglycylglycyl-l-alpha-aspartyl-l-alanyl-l-serylglycyl-l-glutamic Acid
25. Cs-0044577
26. H-trp-ala-gly-gly-asp-ala-ser-gly-glu-oh
27. Delta-sleep Inducing Peptide Trifluoroacetate Salt
28. Q27294600
29. L-tryptophyl-l-alanyl-glycyl-glycyl-l-alpha-aspartyl-l-alanyl-l-seryl-glycyl-l-glutamic Acid
30. (2s)-2-[[2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[2-[[2-[[(2s)-2-[[(2s)-2-amino-3-(1h-indol-3-yl)propanoyl]amino]propanoyl]amino]acetyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]propanoyl]amino]-3-hydroxypropanoyl]amino]acetyl]amino]pentanedioic Acid
31. (3s,9s,12s,15s)-15-(2-(2-((s)-2-((s)-2-amino-3-(1h-indol-3-yl)propanamido)propanamido)acetamido)acetamido)-9-(hydroxymethyl)-12-methyl-5,8,11,14-tetraoxo-4,7,10,13-tetraazahexadecane-1,3,16-tricarboxylic Acid
32. N-[23-amino-11-(carboxymethyl)-1,4,7,10,13,16,19,22-octahydroxy-5-(hydroxymethyl)-24-(1h-indol-3-yl)-8,20-dimethyl-3,6,9,12,15,18,21-heptaazatetracosa-3,6,9,12,15,18,21-heptaen-1-ylidene]glutamic Acid
Molecular Weight | 848.8 g/mol |
---|---|
Molecular Formula | C35H48N10O15 |
XLogP3 | -7.1 |
Hydrogen Bond Donor Count | 14 |
Hydrogen Bond Acceptor Count | 16 |
Rotatable Bond Count | 25 |
Exact Mass | 848.33006086 g/mol |
Monoisotopic Mass | 848.33006086 g/mol |
Topological Polar Surface Area | 407 Ų |
Heavy Atom Count | 60 |
Formal Charge | 0 |
Complexity | 1610 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Neurotransmitter Agents
Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as Neurotransmitter Agents.)